Exhibitor List
Sponsor and Exhibitor Profiles
AstraZeneca
2 Kingdom Street
London W2 6BD
UK
www.astrazeneca.com
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com MedImmune
MedImmune, the worldwide biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE: AZN), is headquartered in Gaithersburg, Maryland. For more information, visit MedImmune’s website at www.medimmune.com
ArcDia International Oy
PO Box 51
Turku, 20521
Finland
www.arcdia.com
www.maripoc.com
ArcDia offers multianalyte products for point-of-care and near-patient testing of respiratory infectious diseases under the trademark mariPOC®. mariPOC® test system covers a broad range of analytes and includes both viruses and bacteria: influenza virus A and B, RSV, parainfluenza virus 1-3, human metapneumovirus, adenovirus, pneumococci and group A streptococci. The automated random-access immunoanalyser is bench-top in size, highly sensitive and easy-to-use. Automated result reading: 20 minutes for high positive and 2 hours for low positive and negative samples. Sensitivity and specificity are similar to laboratory methods and superior to rapid tests. mariPOC® test system is available for distribution and OEM.
Baxter AG
Industriestrasse 67
A-1221 Vienna
Austria
www.baxter.com/baxter_worldwide.html
Baxter is dedicated to improving public health worldwide. Baxter technologies like Vero cell technology have the potential to open the door to a new generation of vaccines. Baxter currently has vaccines licensed against
- Tick-borne encephalitis (TBE)
- Meningococcal C disease
- Pandemic influenza
- Seasonal influenza
Baxter’s mission is the prevention of a broad spectrum of infectious diseases in infants, children and adults.
Binding Site
8 Calthorpe Road, Edgbaston
Birmingham B15 1QT
UK
www.bindingsite.com
Binding Site, a specialist protein company, is committed to improving patient care through development of assays for diagnosis of immunological disorders. For many years Binding Site has been producing high quality products for the investigation of Primary Immunodeficiency and the measurement of the specific antibody response to vaccination. Immunoglobulin, subclass and complement assays are now available on our new benchtop turbidimetric analyser, SPAPLUS. The VaccZyme™ product range offers ELISA kits with a high level of precision and reliability for the measurement of specific IgG against Tetanus, Diphtheria, Haemophilus influenza type b, Streptococcus pneumoniae (Pneumovax™), Salmonella typhi Vi and VZV.
bioMérieux S.A.
Chemin de l’Orme
69280 Marcy l’Etoile
France
www.biomerieux.com
bioMérieux, a world leader in in vitro diagnostics, offers high-medical value solutions for infectious diseases.
Key pediatric applications include:
- An infectious diseases offer comprising bioNexia® rapid tests (results in 5 to 10 minutes) for Influenza, CRP, StrepA and VIKIA® for combined detection of rotavirus and adenovirus.
- A molecular biology product range: ARGENE Respiratory Multi Well System r-geneTM, a new concept for multiple respiratory pathogen detection in the same run using real-time PCR technology.
- VIDAS® B.R.A.H.M.S PCT: improves accuracy of sepsis diagnosis and guides antibiotic prescription.
Visit us on Booth #7 and discover our full range of applications.
Crucell N.V.
Archimedesweg 4-6
2333 CN Leiden
The Netherlands
www.crucell.com
Crucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. We do this by discovering, developing, manufacturing and marketing products that combat major threats to the health of people worldwide. Innovation is the driving force behind our strong research and development pipeline, with promising products in pre-clinical and clinical development. In 2010 alone, Crucell distributed more than 105 million doses of vaccines to people around the world. Our core portfolio includes Quinvaxem®, a liquid pentavalent vaccine against five important childhood diseases; Epaxal®, the only aluminum-free hepatitis A vaccine; Vivotif® and Dukoral®, oral vaccines against typhoid & cholera, and Inflexal® V, a virosomal adjuvanted vaccine against influenza.
European Society for Paediatric Infectious Diseases (ESPID)
1-3 Rue Chantepoulet
CH-1211 Geneva
Switzerland
www.espid.org
The European Society for Paediatric Infectious Diseases (ESPID) exists to promote the exchange of information among people who have special interest and experience in the field of paediatric infectious diseases. The society promotes research and training in PID. ESPID holds its annual meetings in different European locations chosen in a bid process. Membership is granted to individuals supported by at least one existing member at the discretion of the Board. ESPID members receive on a monthly basis The Pediatric Infectious Disease Journal and can benefit from a number of award schemes.
GlaxoSmithkline
Parc de la Noire Epine, Rue Fleming 20
1300 Wavre
Belgium
www.gsk.com
GlaxoSmithKline Biologicals (GSK Biologicals), GlaxoSmithKline’s vaccines business, is one of the world’s leading vaccine companies and a leader in innovation. The company is active in vaccine research, development and production with over 30 vaccines approved for marketing and 20 more in development - both in the prophylactic and therapeutic fields. Headquartered in Belgium, GSK Biologicals has 14 manufacturing sites strategically positioned around the globe. In 2010, GSK Biologicals distributed 1.43 billion doses of vaccines to 179 countries in both the developed and the developing world. Through its accomplished and dedicated workforce, GSK Biologicals applies its expertise to the discovery of innovative vaccines that contribute to the health and well-being of people of all generations around the world. GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information, please visit www.gsk.com
Hot Topics in Infection and Immunity in Children - The ESPID-Oxford Course
University of Oxford Department of Paediatrics
Children's Hospital, Headington
Oxford OX3 9DU
UK
www.oxfordiic.org
Hot Topics in Infection and Immunity in Children, The ESPID-Oxford Course, aims to provide both basic information and updates in key areas of paediatric infectious disease. It is held in Oxford, UK each summer, with 30 leading experts from around the world, providing updates on the latest developments in the field. It is also a residential component of the ESPID-Oxford Postgraduate Diploma in PID.
Nanosphere, Inc.
4088 Commercial Avenue
Northbrook, IL, 60062
USA
www.nanosphere.us
Nanosphere uses the power of nanotechnology to create innovative molecular diagnostics for clinical virology and microbiology laboratories. The CE-marked Verigene System is a sample-to-result platform that can perform on demand testing for pathogens that cause bloodstream, respiratory tract, and gastrointestinal infection.
Novartis Vaccines & Diagnostics, Inc.
350 Massachusetts Avenue
Cambridge, MA 02139
USA
www.novartisvaccines.com
“Caring Begins with Prevention” At Novartis Vaccines and Diagnostics, we believe that caring for patients begins with protecting individuals and societies from infection in the first place. The division has two businesses: Novartis Vaccines and Novartis Diagnostics. Novartis Vaccines is the world’s fifth-largest vaccines manufacturer and the second-largest supplier of influenza vaccines. The division's products include meningococcal, pediatric and travel vaccines.
Novartis Diagnostics is dedicated to providing innovative testing solutions to help protect the world’s blood supply from transfusion-transmitted diseases. We are the world leader in nucleic acid testing for blood screening.
OM Pharma / Vifor Pharma
22, rue du Bois-du-Lan
1217 Meyrin / Geneva
Switzerland
www.viforpharma.com
OM Pharma, a company of the Vifor Pharma Group headquartered in Switzerland, is a world leader in immunoactive therapies. Its leading brand, Broncho-Vaxom®, is indicated in the prevention of respiratory tract infections in adults and children. Vifor Pharma is the pharma business sector of the Galenica Group.
Pfizer Inc.
23-25 Av. du Dr. Lannelongue
75014 Paris
France
www.pfizer.com
Pfizer Inc.: Working together for a healthier world™ At Pfizer we strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many consumer products. Pfizer colleagues advance wellness, prevention, treatments and cures that challenge the most feared diseases. Consistent with our responsibility as the world’s leading biopharmaceutical company, we collaborate with health care providers, governments and local communities to support and expand access to reliable and affordable health care.
Sanofi Pasteur MSD
8, rue Jonas Salk
69367 LYON cedex 07
France
www.spmsd.com
Sanofi Pasteur MSD is dedicated exclusively to vaccines because we believe prevention is better than cure and immunisation is the best prevention. Our 45 vaccines help protect people from 20 infectious diseases, including cervical cancer, liver cancer, tuberculosis, poliomyelitis, measles, yellow fever, shingles and influenza. Sanofi Pasteur MSD is a joint venture between sanofi pasteur and Merck & Co. Inc. We lead the vaccine industry in Western Europe with an estimated 37% of the vaccine market in 2008. Together with sanofi pasteur and Merck we are working to make vaccines available to more people in the developing world, in alliance with organisations such as the World Health Organisation and the Global Alliance for Vaccines and Immunisation.
Statens Serum Institut
Artillerivej 5
2300 Copenhagen S
Denmark
www.ssi.dk/english.aspx
Statens Serum Institut is an enterprise under the Danish Ministry of Interior and Health, and the Institute’s duties are partly integrated in the national Danish health services. Statens Serum Institut prevents and controls infectious diseases, biological threats and congenital disorders. Our expertise includes:
- Monitoring, advising and teaching on the incidence, prevention and treatment of infectious diseases and congenital disorders.
- Specializing in the diagnosis of infectious, autoimmune, congenital and genetic diseases.
- Ensuring the supply of vaccines, other biological products and diagnostic services through production and procurement.
- Preparedness against biological terrorism.
- Research and development in the Institute's areas of activity at an international level.
Statens Serum Institut aims to ensure advanced control of infectious diseases, including new infections and biological threats. The Institute also strives to be a highly regarded and recognized national and international research, production and service enterprise.
Wisepress Medical Bookshop
25 High Path, Merton Abbey
London, SW19 2JL
UK
www.wisepress.com
Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.